Skip to content

iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty Using the Persona Knee System Among Patients With BMI>=30: Radiographic, Clinical and Economic Outcomes

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02117973
Enrollment
60
Registered
2014-04-21
Start date
2014-06-30
Completion date
Unknown
Last updated
2014-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Knee Replacement

Brief summary

The purpose of this prospective randomized study is to evaluate iAssist with respect to radiographic, clinical and economic outcomes in comparison to conventional instrumentation in primary total knee arthroplasty using the Persona knee system among patients with BMI\>=30.

Interventions

PROCEDUREiAssist Technique using Persona system vs. the conventional technique using Persona system

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female 2. Needs a primary TKR on the left or right knee 3. Diagnose of non-inflammatory degenerative joint disease (e.g., osteoarthritis, post-traumatic arthritis, avascular necrosis, etc.) 4. Over 18 years old 5. BMI\>=30 6. Able to: * Understand what participation in the study entails and give written informed consent, and * Follow surgeon/staff instructions, and * Return for all follow-up evaluations, and * Able and willing to undergo a preoperative full-leg, standing radiographs (all cases) * Willing to consent (patient or his/her legal guardian) to participate in the study by signing and dating an approved consent. * Meet an acceptable preoperative medical clearance and is free of or treated for cardiac, pulmonary, hematological or other conditions that would pose excessive operative risk. 7. Presence of varus or valgus deformity of 15 degrees or less.

Exclusion criteria

1. Currently enrolled in an investigational new drug or device study 2. Active Infection (including septic knee, distant infection, or osteomyelitis) 3. Severe hip arthrosis 4. Neurological disorders (including, but not limited to Parkinson's disease) 5. Prior ipsilateral unicompartmental knee arthroplasty, TKA, knee fusion or patellectomy 6. Hip or knee ankylosis 7. Inflammatory joint disease. 8. Either rheumatoid or post-traumatic knee arthritis 9. Scheduled for simultaneous bilateral TKA 10. Indications of intra- and/or extra-articular deformations that would eliminate or tend to eliminate adequate implant support or prevent the use of an appropriately sized implant, such as polio, history of tibial plateau fracture, etc. 11. Any metal within 150 mm of the joint line for the operative-side knee 12. Knee deformities greater than 15 degrees of fixed varus, valgus, or flexion contracture on initial physical examination 13. A female who is pregnant or lactating 14. Current involvement in any personal injury litigation, medical-legal or worker's compensation claims 15. Arterial disease or stents that would exclude the use of a tourniquet 16. Insufficient quality or quantity of bone to support the implant due to prior knee surgery (or surgeries), cancer, metabolic bone disease, osteoporosis/osteopenia (diagnosed or treated with medication), active/old/remote infection, etc. 17. Mental condition that may interfere with his/her ability to give an informed consent or interfere with his/her ability or willingness to fulfill the requirements of the study. 18. Condition that would place excessive demands on the implant (e.g., Charcot's joints, muscle deficiencies, multiple joint disabilities, skeletal immaturity, etc.). 19. Collateral ligament insufficiency. 20. Immunosuppressive disorder (e.g., AIDS, etc.) that would require cytotoxic drugs, corticosteroids, large dose of irradiation, or antilymphocytic serum. 21. An existing condition that would, in the opinion of the investigator, compromise participation or follow-up in this study

Design outcomes

Primary

MeasureTime frameDescription
differences in limb alignment12 MONTHSThe primary endpoint is defined as Limb alignment as determined using radiographs (A/P long-standing and lateral films)

Secondary

MeasureTime frameDescription
difference in Knee Society Score12 MONTHSAssess the differences in Knee Society Score between iAssist and conventional instrumentation in primary TKA procedures.

Other

MeasureTime frameDescription
difference in Oxford knee score12 monthsAssess the differences inOxford knee score between iAssist and conventional instrumentation in primary TKA procedures.
Operating room timethree hoursto compare the operating room time between patients undergoing iAssist vs. conventional instrumentation in primary TKA procedures.
Blood loss and complications12 monthsto compare the blood loss and complications between patients undergoing iAssist vs. conventional instrumentation in primary TKA procedures

Contacts

Primary ContactMeir Libergall, Prof.
liebergall@hadassah.org.il972-2-6777111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026